AXSM SG&A Expense Growth
Axsome Therapeutics Inc · SG&A Expense Growth
AXSM SG&A Expense Growth
Latest reported38.71%period ending
AXSM FY SG&A Growth (YoY) (0.00% → 38.71%)
Latest values, visible window
High-resolution chart · PNG
AXSM sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 38.7107% | |
| 27.3072% | |
| 102.8979% | |
| 138.9551% | |
| 130.6349% | |
| 112.5069% | |
| 45.4098% | |
| 29.7617% | |
| 13.6048% | |
| 162.2113% | |
| 73.6959% | |
| 357.8921% | |
| 0% |